Product Gudie-Brightening Actives

Skin tone is not a single switch. It is a pathway with several stages, and each of our eleven actives works at a different point:

Signal  →  Synthesis  →  Transfer  →  Visible pigment  →  Oxidative dullness
   ↓           ↓                          ↓                       ↓
AminoBright  4BR / 4HR /              TXA                 VC family /
             Arbutin                                      Glutathione

Choosing therefore means answering three questions:

1. Which stage am I targeting? (most launches target more than one)
2. What is my base? — anhydrous oil, water serum, or a near-neutral emulsion
3. What does my market allow me to say? — this varies more than most people expect

Read this before you choose: base compatibility

This is the filter that eliminates options fastest.

Once the base is settled, you are choosing within a shortlist of three or four — not eleven.

Group A — Vitamin C derivatives

Five actives sharing a vitamin C core, differentiated by solubility, stability and pH window.

How to choose within Group A: anhydrous → VC-IP. Maximum penetration in a water serum → 3-O-EA. Gentle daily use → AA2G. Heated near-neutral process → MAP. Blemish-prone positioning → SAP.

Group B — Resorcinol derivatives

Two actives working directly on tyrosinase, at the synthesis stage.

Reference data. Published in vitro tyrosinase inhibition figures — a lower IC50 indicates stronger inhibition:

Source: Int. J. Mol. Sci. 2022 (PMC9305876).

How to choose within Group B: maximum efficacy at low dosage → 4BR. Gentle daily positioning at an accessible cost-in-use → 4HR.

Group C — Signal, transfer and antioxidant actives

★ = flagship grade

How to choose

Build a multi-target claim architecture

Single-ingredient brightening stories are getting harder to defend to retailers. A three-point structure is more convincing and easier to support:

Choose one row from each stage and you have a coherent, defensible story rather than a single hero ingredient.

Formulation notes

• Water-soluble vitamin C derivatives are best added in the cool-down phase, with pH controlled inside the window given in the TDS.
• YL4BR is supplied for pre-dispersion in propylene glycol or ethanol before addition.
• Oxidation management: pair vitamin C systems with an antioxidant partner such as YLGSH, and verify colour stability over accelerated storage.
• Acidic systems: if you are building a low-pH brightening emulsion, pair the actives with YLTRISTAB, which holds pH 3–6.
• Reactive formulas: add YLBMS at 0.2–0.5% where high active loads may cause discomfort.

Claims and compliance notes — read this one carefully

This line carries more regulatory exposure than any other in our portfolio.

Additional considerations:

• Several actives have market-specific concentration caps or registration requirements — notably tranexamic acid, alpha-arbutin and certain resorcinol derivatives. Verify before locking your formula.
• Quantified efficacy claims should always be accompanied by the study conditions.
• Documentation available: batch COA (purity verified), TDS, SDS/MSDS, concentration guidance, documentation where applicable, retained samples and batch traceability.
• Performance figures quoted here come from internal testing and the published literature cited. The official batch COA and test report govern.

Two audiences, two shortlists

If you are a formulator: request YL4BR (efficacy benchmark), YL3-O-EA (water-base benchmark) and YLVC-IP (oil-base benchmark). Every brightening brief is one of those three, usually combined with supporting actives.

If you are a distributor: stock YLVC-IP first — it is stable, premium-positioned, and easy to sell into both skincare and sun care. Add YL4BR once your customers start asking for spot correctors, and YLTXA once eye care comes up. All actives ship in 1 kg units, so trial inventory stays light.

Frequently asked questions

Which brightening active works in an anhydrous oil? YLVC-IP (Ascorbyl Tetraisopalmitate). It is oil-soluble and resists discolouration, unlike water-soluble vitamin C derivatives.

What is the difference between YL4BR and YL4HR? Both are resorcinol derivatives working at the tyrosinase stage. YL4BR (4-butylresorcinol) carries much stronger reported tyrosinase inhibition at very low use levels (0.1–1.0%). YL4HR (hexylresorcinol) is gentler, works well at 0.2–0.5%, and pairs naturally with niacinamide for daily-use products.

Can I use several brightening actives together? Yes — and it often produces a stronger and more defensible claim. A common structure is one signal-level active, one synthesis-level active and one antioxidant. Always confirm tolerance on the finished formula.

Is “whitening” acceptable on-pack? In many markets no, or only with restrictions. “Brightening”, “even skin tone” and “radiance” are the safer defaults. Check local regulation before printing.

What use level should I start at? Follow the suggested addition in the product table, then titrate during development. Several actives in this line are effective well below 1%.

Do you offer custom actives or blends? Yes. Our joint R&D team develops custom derivatives, salt forms, purity grades and compound brightening systems — from lab-scale trial to full production.

Continue through the series

Preservative Alternatives → · Emulsifiers → · Anti-Irritation Soothing → · Synthetic Esters → · Surfactants →

Ready to shortlist? Tell us your base system, target claim and market, and our formulation team will return a recommended active combination with starting use levels, regulatory notes and samples — usually within one working day. Request samples and documentation · fiona@ingrelink.com · +86 186 8017 1796

Guangzhou IngreLink New Material Co., Ltd. — Sincerity · Agility · Win-Win. Data referenced are from internal testing and the published sources cited; the official batch COA and test report govern. Cosmetic ingredients only — not for drug or medical use. Finished-product claims, registration and labelling are the responsibility of the brand.